Evidence map›Paper›PMID 35055974›Full record

ReviewPathogens (Basel, Switzerland)2021

Role of ARP2/3 Complex-Driven Actin Polymerization in RSV Infection.

Autumn Paluck, Jaspreet Osan, Lauren Hollingsworth, Sattya Narayan Talukdar, Ali Al Saegh, Masfique Mehedi

Open access · goldAbstract readReview
In one paragraph

Review in Pathogens (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Exploring Therapeutic Targets From Spreading Patterns Against Respiratory Syncytial Virus.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Autumn PaluckSchool of Medicine and Health Sciences, University of North Dakota, Grand Forks, ND 58202, USA.
Jaspreet OsanSchool of Medicine and Health Sciences, University of North Dakota, Grand Forks, ND 58202, USA.
Lauren HollingsworthSchool of Medicine and Health Sciences, University of North Dakota, Grand Forks, ND 58202, USA.
Sattya Narayan TalukdarSchool of Medicine and Health Sciences, University of North Dakota, Grand Forks, ND 58202, USA.
Ali Al SaeghSchool of Medicine and Health Sciences, University of North Dakota, Grand Forks, ND 58202, USA.
Masfique MehediSchool of Medicine and Health Sciences, University of North Dakota, Grand Forks, ND 58202, USA.
University of North Dakota · USCornell University · US

Funding

Yersina perstis interactions with macrophagesP20GM113123 · NIGMS · UNIVERSITY OF NORTH DAKOTA · PI COMBS, COLIN K · 2016 to 2025
$19.9M
National Institute of Health NIH/NIGMS P20GM113123NIGMS NIH HHS P20 GM113123
6 · The paper itself

Abstract

Respiratory syncytial virus (RSV) is the leading viral agent causing bronchiolitis and pneumonia in children under five years old worldwide. The RSV infection cycle starts with macropinocytosis-based entry into the host airway epithelial cell membrane, followed by virus transcription, replication, assembly, budding, and spread. It is not surprising that the host actin cytoskeleton contributes to different stages of the RSV replication cycle. RSV modulates actin-related protein 2/3 (ARP2/3) complex-driven actin polymerization for a robust filopodia induction on the infected lung epithelial A549 cells, which contributes to the virus's budding, and cell-to-cell spread. Thus, a comprehensive understanding of RSV-induced cytoskeletal modulation and its role in lung pathobiology may identify novel intervention strategies. This review will focus on the role of the ARP2/3 complex in RSV's pathogenesis and possible therapeutic targets to the ARP2/3 complex for RSV.

Indexed as

actin polymerizationARP2/3 complexbronchiolitiscell-to-cell spreadcytoskeleton dynamicsfilopodiaRSVtherapeutics

Identifiers

PMID35055974
PMCPMC8781601
OpenAlexW4200275798

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.